Lineage Cell Therapeutics, Inc.: capex
| Value | {"amount": 497000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2014-01-01 – 2014-09-30 |
| Status | current |
| Entity | Lineage Cell Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:43:16.416080+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c6748a03-0116-4e5f-b69f-3ae710b2b218
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001140361-15-040074 · Open the official SEC filing →Retrieved: 2026-08-19T08:43:16.416080+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000876343/capex/2014-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c6748a03-0116-4e5f-b69f-3ae710b2b218
History
- supersedes {"amount": 497119, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} (evidence 0001140361-14-040755)